Page last updated: 2024-11-07

dextroamphetamine and Retinal Degeneration

dextroamphetamine has been researched along with Retinal Degeneration in 2 studies

Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.

Retinal Degeneration: A retrogressive pathological change in the retina, focal or generalized, caused by genetic defects, inflammation, trauma, vascular disease, or aging. Degeneration affecting predominantly the macula lutea of the retina is MACULAR DEGENERATION. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p304)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Romano, PE1
Hertle, RW1
Maybodi, M1
Bauer, RM1
Walker, K1

Other Studies

2 other studies available for dextroamphetamine and Retinal Degeneration

ArticleYear
September 11; also: dexedrine or surgery for exotropia? Modified Foster; DEP or masked DVD?; You're not very good at gaze and head tilt angles; more on atropine for myopia and ARM.
    Binocular vision & strabismus quarterly, 2001, Volume: 16, Issue:4

    Topics: Atropine; Dextroamphetamine; Dopamine Agents; Exotropia; Humans; Myopia; New York City; Nystagmus, C

2001
Clinical and oculographic response to Dexedrine in a patient with rod-cone dystrophy, exotropia, and congenital aperiodic alternating nystagmus.
    Binocular vision & strabismus quarterly, 2001, Volume: 16, Issue:4

    Topics: Attention Deficit Disorder with Hyperactivity; Child; Dextroamphetamine; Dopamine Agents; Electroocu

2001